University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Hydroxycarbamide capsules

For myeloproliferative disorders. ESCA under development

Status: Green Hyoscine hydrobromide 300microgram tablets

For hypersalivation caused by antipsychotics

Status: Green Hyoscine patch

Very high relative cost

Status: Green Hyoscine tablets

Specialist initiation only

Status: Amber Ibandronic acid tablet

ESCA

Status: Green Ibuprofen suspension

If swallowing difficulties and paediatric use

Status: Red Icatibant (Firazyr®)

NHS England commissioned

Status: Red Ichthammol 1% w/w and zinc oxide 15% w/w in Yellow Soft Paraffin

Unlicensed special

Status: Red Idarubicin injection

For hospital use only

Status: Red Idarucizumab 2.5g/250ml solution for injection/infusion

When rapid reversal of Dabigatran anticoagulant effect is required

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top